Putting Nicotinic Compounds to Good Use along Tobacco Road

Nov. 17, 2005
R.J. Reynolds’ spinoff Targacept is the leader in using nicotinic compounds for therapeutic benefit. Bill Caldwell, VP of drug discovery and development, tells why and shares tech transfer secrets in this exclusive audio interview.
Click the Download Now button to access this 2,173 KB mp3 audio file.
About the Author

Paul Thomas | Managing Editor